EUS- and US- Guided Biopsy for Pancreatic Lesion
ConditionPancreatic Cancer
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-85
SponsorTian'an Jiang
About this trial
Endoscopic ultrasound (EUS) and ultrasound (US) are the two primary imaging modalities used to guide pancreatic needle biopsy. This study aimed to compare the diagnostic performance and complications associated with EUS- and US-guided pancreatic biopsies.
Eligibility criteria
Qualifiers
Between January 2017 and December 2023, 2663 consecutive patients with focal pancreatic disease underwent 2729 procedures for pancreatic tissue acquisition from focal pancreatic lesions at seven university teaching hospitals in China.
Disqualifiers
Patients were excluded from the study if they had less than 12 months of follow-up, were lost to follow-up, had incomplete follow-up data, or underwent intraoperative biopsy or fluid aspiration.
Trial design
Treatments tested in this trial
- sampling tissue
Treatment groups
No treatment groups listed
Locations
Sponsors and collaborators
Tian'an Jiang
Lead sponsor
First Affiliated Hospital of Zhejiang University
Sponsor institution
Source ClinicalTrials.gov